⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for esophageal cancers

Every month we try and update this database with for esophageal cancers cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerNCT03929666
HER2-expressing...
ZW25 (Zanidatam...
Capecitabine
Cisplatin
Fluorouracil
Leucovorin
Oxaliplatin
Bevacizumab
Gemcitabine
18 Years - Jazz Pharmaceuticals
Surgery or Chemoradiation for Esophageal CancerNCT01032967
Esophageal Canc...
Esophagectomy
Definitive chem...
18 Years - 75 YearsChinese University of Hong Kong
Surgery or Chemoradiation for Esophageal CancerNCT01032967
Esophageal Canc...
Esophagectomy
Definitive chem...
18 Years - 75 YearsChinese University of Hong Kong
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerNCT03929666
HER2-expressing...
ZW25 (Zanidatam...
Capecitabine
Cisplatin
Fluorouracil
Leucovorin
Oxaliplatin
Bevacizumab
Gemcitabine
18 Years - Jazz Pharmaceuticals
A Dose Finding Study of ZW49 in Patients With HER2-Positive CancersNCT03821233
HER2-expressing...
ZW49
18 Years - Zymeworks BC Inc.
Surgery or Chemoradiation for Esophageal CancerNCT01032967
Esophageal Canc...
Esophagectomy
Definitive chem...
18 Years - 75 YearsChinese University of Hong Kong
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersNCT05152147
Gastric Neoplas...
Gastroesophagea...
Esophageal Aden...
Zanidatamab
Tislelizumab
Trastuzumab
Capecitabine
Oxaliplatin
Cisplatin
5-Fluorouracil
18 Years - Jazz Pharmaceuticals
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: